Psychotic episode induced by potential drug interaction of sibutramine and finasteride;Surto psicótico pela possível interação medicamentosa de sibutramina com finasterida

Revista Brasileira de Psiquiatria

Volumn 24, Issue 1, 2002, Pages 30-33

  Sucar, Douglas Dogol ^a,c   Sougey, Everton Botelho ^b   Neto, E José Brandão ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c Douglas Dogol Sucar   (Brazil)

Author keywords

Case report; Drug interaction; Finasteride.; Sibutramine

Indexed keywords

ANTIOBESITY AGENT; DOPAMINE; FINASTERIDE; NORADRENALIN; SEROTONIN; SIBUTRAMINE; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; ALOPECIA; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG PROTEIN BINDING; HUMAN; MALE; MENTAL DISEASE; NEUROTRANSMISSION; OBESITY; PARANOIA; PSYCHOSIS;

EID: 18344397736     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462002000100009     Document Type: Article

References (22)

1. Male pattern baldness: Classification and incidence
2. General evaluation of the patient with alopecia
3. The nutrition transition in Brazil
4. Obesidade, esse grande "Iceberg"
5. Epidemiology of obesity and its link to heart disease
6. Body weight and mortality among women
7. Protocolo de documentação dos efeitos adversos, induzidos pela interação medicamentosa dos psicotrópicos com os outros medicamentos da clínica médica geral
8. Androgênios
9. Weight loss profile with sibutramine in obese patients with type 2 diabetes: A double-blind, placebo-controlled study
10. The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant witch induces rapid noradrenergic down-regulation
11. Sibutramine hydrochloride: Evaluation of abuse potential
12. Interação medicamentosa de venlafaxina com captopril
13. Sibutramine: A novel new agent for obesity treatment
14. Finasteride
15. Finasteride a steroid 5-alphareductase inhibitor does not affect the oxidative metabolism of antipyrine